Suppr超能文献

医源性脑淀粉样血管病:一种新发病例的说明。

Iatrogenic cerebral amyloid angiopathy: An illustrative case of a newly introduced disease.

机构信息

Cerebrovascular Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Department of Neurology, Hannover Medical School, Hannover, Germany.

出版信息

Eur J Neurol. 2023 Oct;30(10):3397-3399. doi: 10.1111/ene.15997. Epub 2023 Aug 8.

Abstract

BACKGROUND AND PURPOSE

Iatrogenic cerebral amyloid angiopathy (iCAA) is a specific type of cerebral amyloid angiopathy which is becoming increasingly diagnosed. It has been hypothesized that iCAA might arise as a late consequence of past neurosurgical interventions involving dural patch grafts. Positron emission tomography (PET) scans with amyloid tracers and the assay of beta-amyloid levels in cerebrospinal fluid (CSF) are auxiliary criteria, however, definite diagnosis remains histopathologically determined.

METHODS

Case report.

RESULTS

We present a 48-year-old patient who suffered multiple lobar cerebral haemorrhages from the age of 47. The patient had undergone surgery for remolval of hemangioblastoma with lyophilized dural graft at the age of 11, in 1987. Brain MRI, amiloid PET and CSF analysis led to a diagnosis of probable iCAA.

CONCLUSION

It is necessary to increase the awareness of iCAA, in order to avoid overlooking the potential causal involvement of surgical procedures which took place far back in time. Moreover, the diagnostic relevance of amyloid PET and beta-amyloid levels in CSF must be emphasised.

摘要

背景与目的

医源性脑淀粉样血管病(iCAA)是一种日益被诊断出来的特定类型的脑淀粉样血管病。人们假设 iCAA 可能是过去涉及硬脑膜补丁移植物的神经外科干预的晚期后果。正电子发射断层扫描(PET)扫描用淀粉样蛋白示踪剂和脑脊液(CSF)中β-淀粉样蛋白水平的测定是辅助标准,然而,明确的诊断仍然依赖于组织病理学确定。

方法

病例报告。

结果

我们介绍了一位 48 岁的患者,他从 47 岁开始多次发生额叶脑叶出血。该患者于 1987 年 11 岁时因血管母细胞瘤切除术接受了冻干硬脑膜移植物手术。脑部 MRI、淀粉样 PET 和 CSF 分析导致可能的 iCAA 诊断。

结论

有必要提高对 iCAA 的认识,以避免忽略远在过去的手术程序的潜在因果关系。此外,必须强调淀粉样蛋白 PET 和 CSF 中β-淀粉样蛋白水平的诊断相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验